Director/PDMR Shareholding (9346A)
09 February 2011 - 9:25PM
UK Regulatory
TIDMGWP
RNS Number : 9346A
GW Pharmaceuticals PLC
09 February 2011
GW Pharmaceuticals PLC
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the
"Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 9 February 2011: GW Pharmaceuticals (AIM: GWP)
hereby provides notification that the Company has today been
notified of the following share transactions entered into on 4
February 2011 by Mr Thomas Lynch, non-executive Director and Dr
Geoffrey Guy, a Director and Executive Chairman of the Company.
Mr Thomas Lynch purchased 188,679 ordinary shares of 0.1p each
from Dr Geoffrey Guy. This transaction between Directors, which
equates to 0.14% of the issued ordinary share capital of the
company, took place at the market price of 106 pence per share.
Following this notification:
Mr Lynch's holding in the shares of GW Pharmaceuticals PLC has
increased to 236,344 ordinary shares of 0.1 pence each, amounting
to 0.18% of shares in issue.
Dr Guy holds a beneficial interest in 18,068,104GW
Pharmaceuticals plc ordinary shares of 0.1 pence each, representing
13.73% of the Company's current issued share capital.
The total number of shares outstanding in the Company is
131,549,592 ordinary shares of 0.1 pence each.
- Ends -
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Advisor) Tel: +44 (0)207 418 8900
James Steel/Vijay Barathan
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFFIFSIAIIL
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024